The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

DSpace Repository

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

Author: Muenchow, Alina; Weller, Sandra; Hinterleitner, Clemens; Malenke, Elke; Bugl, Stefanie; Wirths, Stefan; Mueller, Martin R.; Schulze-Osthoff, Klaus; Aulitzky, Walter E.; Kopp, Hans-Georg; Essmann, Frank
Tübinger Autor(en):
Weller, Sandra
Hinterleitner, Clemens
Malenke, Elke
Bugl, Stefanie
Wirths, Stefan
Schulze-Osthoff, Klaus
Kopp, Hans-Georg
Essmann, Frank
Müller, Martin Rudolf
Published in: Cell Death & Disease (2020), Bd. 11, Article 701
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/s41419-020-02910-2
ISSN: 2041-4889
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)